003220.KS
Daewon Pharmaceutical Co., Ltd.
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 7,990.00
−1.36%Margins
Gross margin
44.9%
EBITDA margin
-6.7%
EBIT margin
-0.0%
Net margin
0.4%
FCF margin
0.3%
1.0%
Return on equity
0.5%
Return on assets
-0.0%
Return on invested capital
1.05x
Asset turnover
KRW 25.2B
Cash from operations
KRW 3.1K
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026